268
Views
0
CrossRef citations to date
0
Altmetric
Human Population Biology

MTHFR and MTRR gene polymorphisms in patients with chronic hepatitis B virus infections in Zigong, Sichuan Province

ORCID Icon, , &
Article: 2330926 | Received 26 Oct 2023, Accepted 29 Feb 2024, Published online: 18 Apr 2024

References

  • Bao L, Shen D, Yang Y, Zhang H, Guo X. 2021. Study on gene polymorphism of folate metabolism related enzymes MTHFR and MTRR in Gansu. Lab Med Clinic. 18:1–7.
  • Bureau of Medical Administration, National Health Commission of the People’s Republic of China. 2020. Standard of diagnosis and treatment of primary liver cancer (2019 edition). J Clin Hepatology. 36 (2):277–292.
  • Chen Y, Ren X, Li Y, Li H. 2020. Study on the distribution of MTHFR gene polymorphism among Han population in Luzhou and the correlation between MTHFR gene polymorphism and recurrent spontaneous abortion in women of childbearing age. Matern Child Health Care China. 5:87–90.
  • Chinese Society of Infectious Diseases, Chinese Medical Association, Chinese Society of Hepatology, Chinese Medical Association. 2019. [The guidelines of prevention and treatment for chronic hepatitis B (2019 version)]. Zhonghua Gan Zang Bing Za Zhi. 27:938–961. doi: 10.3760/cma.j.issn.1007-3418.2019.12.007.
  • Fang L, Mu C, Zhang L, Xu Y, Zhao W, Chen Y. 2018. Study on distributions of MTHFR C677T gene polymorphism in pregnant women from northeast of Sichuan. Genomics Appl Biol. 37:1820–1824.
  • Jiajin L, Shuyan C, Ying W, Junxiao C, Xiudi W. 2019. Genetic polymorphisms in folate metabolism as risk for Down syndrome in the southern China. J Matern Fetal Neonatal Med. 32(12):2030–2035. doi: 10.1080/14767058.2018.1424818.
  • Jiao X, Luo Y, Yang B, Jing L, Li Y, Liu C, Jing X, Wang F, Wang Y, Du Z, et al. 2017. The MTHFR C677T mutation is not a risk factor recognized for HBV-related HCC in a population with a high prevalence of this genetic marker. Infect Genet Evol. 49:66–72. doi: 10.1016/j.meegid.2017.01.008.
  • Kwak SY, Kim UK, Cho HJ, Lee HK, Kim HJ, Kim NK, Hwang SG. 2008. Methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) gene polymorphisms as risk factors for hepatocellular carcinoma in a Korean population. Anticancer Res. 28:2807–2811.
  • Li D, Ye A, Gan Y, Li P, Wu J, Qiu L. 2019. Analysis for polymorphism of MTHFR C677T gene in Han population in Beijing. Linchuang Jian Yan Za Zhi. 2:156–160.
  • Lu D, Zhuo J, Yang M, Wang C, Pan L, Xie H, Xu X, Zheng S. 2018. The association between donor genetic variations in one-carbon metabolism pathway genes and hepatitis B recurrence after liver transplantation. Gene. 663:121–125. doi: 10.1016/j.gene.2018.03.071.
  • Markan S, Sachdeva M, Sehrawat BS, Kumari S, Jain S, Khullar M. 2007. MTHFR 677 CT/MTHFR 1298 CC genotypes are associated with increased risk of hypertension in Indians. Mol Cell Biochem. 302(1-2):125–131. doi: 10.1007/s11010-007-9434-5.
  • Nasri K, Midani F, Kallel A, Ben Jemaa N, Aloui M, Boulares M, Lassoued M, Ben Halima M, Ben Wafi S, Soussi M, et al. 2019. Association of MTHFR C677T, MTHFR A1298C, and MTRR A66G polymorphisms with neural tube defects in Tunisian parents. Pathobiology. 86(4):190–200. doi: 10.1159/000499498.
  • Qiao K, Zhang S, Huo Z, Hou W, Dai Q, Su R, Wang F. 2020. LINE-1 methylation in chronic HBV infected patients: association with HCC, gender and MTHFR C677T polymorphism. Clin Lab. 66(5):1–6. doi: 10.7754/Clin.Lab.2019.190906.
  • Qiao K, Zhang S, Trieu C, Dai Q, Huo Z, Du Y, Lu W, Hou W. 2017. Genetic polymorphism of MTHFR C677T influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population: a case-control study. Clin Lab. 63(4):787–795. doi: 10.7754/Clin.Lab.2016.161003.
  • Reeves SG, Meldrum C, Groombridge C, Spigelman AD, Suchy J, Kurzawski G, Lubinski J, McElduff P, Scott RJ. 2009. MTHFR 677 C > T and 1298 A > C polymorphisms and the age of onset of colorectal cancer in hereditary nonpolyposis colorectal cancer. Eur J Hum Genet. 17(5):629–635. doi: 10.1038/ejhg.2008.239.
  • Spiroski I, Kedev S, Antov S, Arsov T, Krstevska M, Dzhekova-Stojkova S, Kostovska S, Trajkov D, Petlichkovski A, Strezova A, et al. 2008. Association of methylenetetrahydrofolate reductase (MTHFR-677 and MTHFR-1298) genetic polymorphisms with occlusive artery disease and deep venous thrombosis in Macedonians. Croat Med J. 49(1):39–49. doi: 10.3325/cmj.2008.1.39.
  • Vilms EA, Turchaninov DV, Antonova IV, Kozubenko OV. 2023. [Assessment of the role of nutritional and genetic determinants in the formation of the risk of diseases associated with folate cycle disorders in the population of the Omsk region]. Vopr Pitan. 92(2):35–42. doi: 10.33029/0042-8833-2023-92-2-35-42.
  • Xiang Y, Zhao Q, Liu YL, Liu YJ, Lv J. 2019. Polymorphism of methylenetetrahydrofolate reductase gene in women of childbearing age in Suining region. J Mod Med Health. 35:2108–2112.
  • Xu W, Yu J, Wong VW. 2017. Mechanism and prediction of HCC development in HBV infection. Best Pract Res Clin Gastroenterol. 31(3):291–298. doi: 10.1016/j.bpg.2017.04.011.
  • Yang B, Liu Y, Li Y, Fan S, Zhi X, Lu X, Wang D, Zheng Q, Wang Y, Wang Y, et al. 2013. Geographical distribution of MTHFR C677T, A1298C and MTRR A66G gene polymorphisms in China: findings from 15357 adults of Han nationality. PLoS One. 8(3):e57917. doi: 10.1371/journal.pone.0057917.
  • Zappacosta B, Graziano M, Persichilli S, Di Castelnuovo A, Mastroiacovo P, Iacoviello L. 2014. 5,10-Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms: genotype frequency and association with homocysteine and folate levels in middle-southern Italian adults. Cell Biochem Funct. 32(1):1–4. doi: 10.1002/cbf.3019.
  • Zhang S, Jiang J, Tang W, Liu L. 2020. Methylenetetrahydrofolate reductase C677T (Ala > Val, rs1801133 C > T) polymorphism decreases the susceptibility of hepatocellular carcinoma: a meta-analysis involving 12,628 subjects. Biosci Rep. 40(2):1–12. doi: 10.1042/bsr20194229.
  • Zhang Y, Zhu Z, Wang W. 2012. Polymorphism of MTHFR and MTRR among Han women in Deyang, Sichuan. Chin J Evid-Based Med. 12:631–634.